Literature DB >> 25375911

Tumor sequencing takes off, but insurance reimbursement lags.

Shraddha Chakradhar.   

Abstract

Mesh:

Year:  2014        PMID: 25375911     DOI: 10.1038/nm1114-1220

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  1 in total

1.  Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing.

Authors:  Garrett M Frampton; Alex Fichtenholtz; Geoff A Otto; Kai Wang; Sean R Downing; Jie He; Michael Schnall-Levin; Jared White; Eric M Sanford; Peter An; James Sun; Frank Juhn; Kristina Brennan; Kiel Iwanik; Ashley Maillet; Jamie Buell; Emily White; Mandy Zhao; Sohail Balasubramanian; Selmira Terzic; Tina Richards; Vera Banning; Lazaro Garcia; Kristen Mahoney; Zac Zwirko; Amy Donahue; Himisha Beltran; Juan Miguel Mosquera; Mark A Rubin; Snjezana Dogan; Cyrus V Hedvat; Michael F Berger; Lajos Pusztai; Matthias Lechner; Chris Boshoff; Mirna Jarosz; Christine Vietz; Alex Parker; Vincent A Miller; Jeffrey S Ross; John Curran; Maureen T Cronin; Philip J Stephens; Doron Lipson; Roman Yelensky
Journal:  Nat Biotechnol       Date:  2013-10-20       Impact factor: 54.908

  1 in total
  8 in total

Review 1.  Precision medicine for advanced prostate cancer.

Authors:  Stephanie A Mullane; Eliezer M Van Allen
Journal:  Curr Opin Urol       Date:  2016-05       Impact factor: 2.309

2.  Insurance companies are slow to cover next-generation sequencing.

Authors:  Shraddha Chakradhar
Journal:  Nat Med       Date:  2015-03       Impact factor: 53.440

3.  Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies.

Authors:  Julia R Trosman; Christine B Weldon; Michael P Douglas; Patricia A Deverka; John B Watkins; Kathryn A Phillips
Journal:  Value Health       Date:  2017-01       Impact factor: 5.725

Review 4.  Implementation of "clinical sequencing" in cancer genome medicine in Japan.

Authors:  Takashi Kohno
Journal:  Cancer Sci       Date:  2018-02-02       Impact factor: 6.716

5.  Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: A hospital-based study.

Authors:  Kuniko Sunami; Hitoshi Ichikawa; Takashi Kubo; Mamoru Kato; Yutaka Fujiwara; Akihiko Shimomura; Takafumi Koyama; Hiroki Kakishima; Mayuko Kitami; Hiromichi Matsushita; Eisaku Furukawa; Daichi Narushima; Momoko Nagai; Hirokazu Taniguchi; Noriko Motoi; Shigeki Sekine; Akiko Maeshima; Taisuke Mori; Reiko Watanabe; Masayuki Yoshida; Akihiko Yoshida; Hiroshi Yoshida; Kaishi Satomi; Aoi Sukeda; Taiki Hashimoto; Toshio Shimizu; Satoru Iwasa; Kan Yonemori; Ken Kato; Chigusa Morizane; Chitose Ogawa; Noriko Tanabe; Kokichi Sugano; Nobuyoshi Hiraoka; Kenji Tamura; Teruhiko Yoshida; Yasuhiro Fujiwara; Atsushi Ochiai; Noboru Yamamoto; Takashi Kohno
Journal:  Cancer Sci       Date:  2019-04-02       Impact factor: 6.716

6.  Sequencing and curation strategies for identifying candidate glioblastoma treatments.

Authors:  Mayu O Frank; Takahiko Koyama; Kahn Rhrissorrakrai; Nicolas Robine; Filippo Utro; Anne-Katrin Emde; Bo-Juen Chen; Kanika Arora; Minita Shah; Heather Geiger; Vanessa Felice; Esra Dikoglu; Sadia Rahman; Alice Fang; Vladimir Vacic; Ewa A Bergmann; Julia L Moore Vogel; Catherine Reeves; Depinder Khaira; Anthony Calabro; Duyang Kim; Michelle F Lamendola-Essel; Cecilia Esteves; Phaedra Agius; Christian Stolte; John Boockvar; Alexis Demopoulos; Dimitris G Placantonakis; John G Golfinos; Cameron Brennan; Jeffrey Bruce; Andrew B Lassman; Peter Canoll; Christian Grommes; Mariza Daras; Eli Diamond; Antonio Omuro; Elena Pentsova; Dana E Orange; Stephen J Harvey; Jerome B Posner; Vanessa V Michelini; Vaidehi Jobanputra; Michael C Zody; John Kelly; Laxmi Parida; Kazimierz O Wrzeszczynski; Ajay K Royyuru; Robert B Darnell
Journal:  BMC Med Genomics       Date:  2019-04-25       Impact factor: 3.063

7.  Clinical benefit for clinical sequencing using cancer panel testing.

Authors:  Sadaaki Nishimura; Atsushi Sugimoto; Shuhei Kushiyama; Shingo Togano; Kenji Kuroda; Yurie Yamamoto; Makoto Yamauchi; Toshiyuki Sumi; Hiroyasu Kaneda; Tomoya Kawaguchi; Minoru Kato; Mizuki Tagami; Naoto Oebisu; Manabu Hoshi; Kenjiro Kimura; Shoji Kubo; Kazuya Muguruma; Tsutomu Takashima; Masaichi Ohira; Masakazu Yashiro
Journal:  PLoS One       Date:  2021-02-26       Impact factor: 3.240

8.  A patient-driven clinicogenomic partnership for metastatic prostate cancer.

Authors:  Jett Crowdis; Sara Balch; Lauren Sterlin; Beena S Thomas; Sabrina Y Camp; Michael Dunphy; Elana Anastasio; Shahrayz Shah; Alyssa L Damon; Rafael Ramos; Delia M Sosa; Ilan K Small; Brett N Tomson; Colleen M Nguyen; Mary McGillicuddy; Parker S Chastain; Meng Xiao He; Alexander T M Cheung; Stephanie Wankowicz; Alok K Tewari; Dewey Kim; Saud H AlDubayan; Ayanah Dowdye; Benjamin Zola; Joel Nowak; Jan Manarite; Idola Henry Gunn; Bryce Olson; Eric S Lander; Corrie A Painter; Nikhil Wagle; Eliezer M Van Allen
Journal:  Cell Genom       Date:  2022-08-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.